Track topics on Twitter Track topics that are important to you
This study will investigate the safety and effectiveness of a modified stem cell transplant procedure for treating chronic granulomatous disease (CGD) in patients with active infection. CG...
Nexell Therapeutics Inc.(NASDAQ: NEXL), formerly known as VIMRX Pharmaceuticals Inc., is the leading developer and marketer of innovative diagnostics and ex vivo cell therapies for cancer, autoimmune,...
We have published hundreds of NEXELL news stories on BioPortfolio along with dozens of NEXELL Clinical Trials and PubMed Articles about NEXELL for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NEXELL Companies in our database. You can also find out about relevant NEXELL Drugs and Medications on this site too.